EUVIMEDEUVIMED entdecken
Crossref

An on‐Demand Oxygen Nano‐vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy

Sidi Zhang, Xinghui Wang, Xiaojing Chen, Duohuo Shu, Quankun Lin, Hanbing Zou, Jialin Dong, Bing Wang, Qianyun Tang, Huishan Li, Xiaoxiang Chen, Jun Pu und 2 weitere

Advanced Materials · 2025

DOI: 10.1002/adma.202409378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Sidi Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute. Ren Ji Hospital School of Medicine, Shanghai Jiao Tong University, Sh…. Hauptthemen laut MEDLINE: Oxygen, Immunotherapy, Oligodeoxyribonucleotides, Drug Carriers. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shang Hai Sailing Program, Foundation of Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia severely limits the antitumor immunotherapy for breast cancer. Although efforts to alleviate tumor hypoxia and drug delivery using diverse nanostructures achieve promising results, the creation of a versatile controllable oxygen‐releasing nano‐platform for co‐delivery with immunostimulatory molecules remains a persistent challenge. To address this problem, a versatile oxygen controllable releasing vehicle PFOB@F127@PDA (PFPNPs) is developed, which effectively co‐delivered either protein drug lactate oxidase (LOX) or nucleic acids drug unmethylated cytosine‐phosphate‐guanine oligonucleotide (CpG ODNs). Upon photothermal heating, this platform triggered oxygen release, thereby augmenting LOX‐mediated lactate detection rates, and improving T cells infiltrating and cytokine expression. Moreover, under an oxygenated tumor microenvironment (TME), PFPNPs co‐delivered with CpG ODNs effectively reprogrammed the immunosuppressive TME by repolarizing macrophages to an M1‐like phenotype, promoting dendritic cells maturation, and increasing tumor‐infiltrating T cells while decreasing the ratio of regulatory T cells (Tregs). Our study demonstrated that this controlled oxygen‐releasing platform possessed adaptive drug‐loading capabilities to meet varied immunotherapeutic demands in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxygenImmunotherapyOligodeoxyribonucleotidesDrug CarriersNanoparticlesAnimalsMiceTumor MicroenvironmentHumansMixed Function OxygenasesCell Line, TumorFemaleDendritic Cells

Stichwörter der Autor:innen

drug deliveryimmunotherapynano‐platformoxygen controllable releasing

Substanzen

OxygenOligodeoxyribonucleotideslactate 2-monooxygenaseMixed Function OxygenasesCPG-oligonucleotideDrug Carriers

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute. Ren Ji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, P. R. China.
  • State Key Laboratory for Cancer Systems Regulation and Clinical Translation, Jiading District Central Medicine Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, 201800, P. R. China.
  • Central Laboratory Ren Ji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Allergy Department Ren Ji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Department of Urology, Shanghai Pudong New Area People's Hospital, Shanghai, 201299, P. R. China.

ORCID-Profile: Peifeng Liu

Förderung

  • National Natural Science Foundation of China
  • Shang Hai Sailing Program
  • Foundation of Shanghai Municipal Health Commission
  • Medical Transformation Crossing Funding from Shanghai Jiao Tong University
  • construction project-Chongming Whole population whole life cycle cluster clinical research Center construction

Zitieren

APA

Zhang, S., Wang, X., Chen, X., Shu, D., Lin, Q., Zou, H., Dong, J., Wang, B., Tang, Q., Li, H., Chen, X., Pu, J., Gu, B., & Liu, P. (2025). An on‐Demand Oxygen Nano‐vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202409378

Vancouver

Zhang S, Wang X, Chen X, Shu D, Lin Q, Zou H, et al. An on‐Demand Oxygen Nano‐vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy. Advanced Materials. 2025. doi:10.1002/adma.202409378

BibTeX
@article{Zhang2025,
  author = {Zhang, Sidi and Wang, Xinghui and Chen, Xiaojing and Shu, Duohuo and Lin, Quankun and Zou, Hanbing and Dong, Jialin and Wang, Bing and Tang, Qianyun and Li, Huishan and Chen, Xiaoxiang and Pu, Jun and Gu, Bin and Liu, Peifeng},
  title = {An on‐Demand Oxygen Nano‐vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202409378}
}
Kostenlos starten →